Vericel Corporation: Hard To Justify Current Valuation

We are currently offering a one-month trial into the Biotech Forum at half the regular price. To see what I and the other season biotech investors are targeting as trading ideas in real-time, just join our community at The Biotech Forum by clicking HERE .Today, we take a deeper peak at Vericel Corporation (NASDAQ: VCEL ) whose stock has moved up some 40% in recent months. The company is moving to profitably this fiscal year and is seeing impressive sales growth. That said, after the recent rise in equity, v ...